Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sina Rashedi

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
The New England Journal of Medicine|September 1, 2025
Apixaban for Extended Treatment of Provoked Venous ThromboembolismGregory Piazza, Behnood Bikdeli, Arvind K Pandey, et al.
Journal of Cardiovascular Pharmacology|March 18, 2025
A Multifaceted Intervention to Mitigate the Adverse Cardiovascular Effects of Air Pollution: A Feasibility Randomized Controlled TrialParham Sadeghipour, Azita H Talasaz, Sina Rashedi, et al.
JAMA Cardiology|March 29, 2026
Extended Low-Dose Apixaban and Superficial Vein Thrombosis: Post Hoc Analysis of the HI-PRO Randomized Clinical TrialSina Rashedi, Mariana Pfeferman, Arvind Pandey, et al.
Thrombosis and Haemostasis|January 28, 2026
Optimizing the Accuracy of Natural Language Processing Tools for Pulmonary Embolism Detection Through Integration with Claims Data: The PE-EHR+ StudySina Rashedi, Syed Bukhari, Darsiya Krishnathasan, et al.
Thrombosis and Haemostasis|June 25, 2026
Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study DesignBassil Bacare, Syed Bukhari, Nathan Watson, et al.
Seminars in Thrombosis and Hemostasis|March 1, 2024
Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved IndicationsSina Rashedi, Christie M Greason, Parham Sadeghipour, et al.
Journal of the American College of Cardiology|February 7, 2025
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized TrialsSina Rashedi, Mohammad Keykhaei, Alyssa Sato, et al.
Journal of the American College of Cardiology|October 1, 2025
Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future DirectionsSina Rashedi, Hannah Leyva, Nada Hamade, et al.
JAMA Cardiology|October 19, 2022
Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical TrialParham Sadeghipour, Yaser Jenab, Jamal Moosavi, et al.
Thrombosis Research|September 24, 2025
Safety and effectiveness of statins in hospitalized patients with COVID-19: Systematic review and collaborative meta-analysis of randomized controlled trialsLuis Ortega-Paz, Azita H Talasaz, Parham Sadeghipour, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|September 1, 2025
Apixaban for Extended Treatment of Provoked Venous ThromboembolismGregory Piazza, Behnood Bikdeli, Arvind K Pandey, et al.
Journal of Cardiovascular Pharmacology|March 18, 2025
A Multifaceted Intervention to Mitigate the Adverse Cardiovascular Effects of Air Pollution: A Feasibility Randomized Controlled TrialParham Sadeghipour, Azita H Talasaz, Sina Rashedi, et al.
JAMA Cardiology|March 29, 2026
Extended Low-Dose Apixaban and Superficial Vein Thrombosis: Post Hoc Analysis of the HI-PRO Randomized Clinical TrialSina Rashedi, Mariana Pfeferman, Arvind Pandey, et al.
Thrombosis and Haemostasis|January 28, 2026
Optimizing the Accuracy of Natural Language Processing Tools for Pulmonary Embolism Detection Through Integration with Claims Data: The PE-EHR+ StudySina Rashedi, Syed Bukhari, Darsiya Krishnathasan, et al.
Thrombosis and Haemostasis|June 25, 2026
Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study DesignBassil Bacare, Syed Bukhari, Nathan Watson, et al.
Seminars in Thrombosis and Hemostasis|March 1, 2024
Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved IndicationsSina Rashedi, Christie M Greason, Parham Sadeghipour, et al.
Journal of the American College of Cardiology|February 7, 2025
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized TrialsSina Rashedi, Mohammad Keykhaei, Alyssa Sato, et al.
Journal of the American College of Cardiology|October 1, 2025
Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future DirectionsSina Rashedi, Hannah Leyva, Nada Hamade, et al.
JAMA Cardiology|October 19, 2022
Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical TrialParham Sadeghipour, Yaser Jenab, Jamal Moosavi, et al.
Thrombosis Research|September 24, 2025
Safety and effectiveness of statins in hospitalized patients with COVID-19: Systematic review and collaborative meta-analysis of randomized controlled trialsLuis Ortega-Paz, Azita H Talasaz, Parham Sadeghipour, et al.
Pageof 6